+ Follow BLEEDS Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 844966
[Title] => Hemophiliacs among us
[Summary] => Over a thousand people in the country have been confirmed to be hemophiliacs as of July 2012; 944 of them suffer from Hemophilia A, while the other 145 from Hemophilia B.
[DatePublished] => 2012-09-03 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[1] => Array
(
[ArticleID] => 225183
[Title] => Analysis shows safety of post-stroke therapy
[Summary] => Meta-analysis of nearly 340,000 post-stroke patients shows the superior safety of dipyridamole plus aspirin therapy.
The results of the analysis presented at the recent American Heart Associations annual meeting, showed that the therapy was associated with the lowest bleeding risk compared with conventional dose and platelet therapies.
The meta-analysis included data from 50 clinical trials published from 1988 to 2002, with a total of 338,191 patients, to determine bleeding risks associated with antiplatelet agents.
[DatePublished] => 2003-10-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
BLEEDS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 844966
[Title] => Hemophiliacs among us
[Summary] => Over a thousand people in the country have been confirmed to be hemophiliacs as of July 2012; 944 of them suffer from Hemophilia A, while the other 145 from Hemophilia B.
[DatePublished] => 2012-09-03 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[1] => Array
(
[ArticleID] => 225183
[Title] => Analysis shows safety of post-stroke therapy
[Summary] => Meta-analysis of nearly 340,000 post-stroke patients shows the superior safety of dipyridamole plus aspirin therapy.
The results of the analysis presented at the recent American Heart Associations annual meeting, showed that the therapy was associated with the lowest bleeding risk compared with conventional dose and platelet therapies.
The meta-analysis included data from 50 clinical trials published from 1988 to 2002, with a total of 338,191 patients, to determine bleeding risks associated with antiplatelet agents.
[DatePublished] => 2003-10-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
October 23, 2003 - 12:00am